MALAT-1 could also exert its oncogenic effects through mediation of EZH2, miR-216a, miR-217, miR-200c, or Hippo-YAP signaling in pancreatic cancers [58,62,64,65,66]. This evidence concerns the gene EZH2 and pancreatic neoplasm.